Clinical Trials Browser

Phase 1 × Enrolling by invitation × Other hematologic neoplasm × Clear all

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT07014462 2025-10-06

DLIT-AML

Phase 1 Enrolling by invitation

20 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07168486 2025-09-11

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Phase 1 Enrolling by invitation

15 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT04488354 2025-01-10

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Phase 1 Enrolling by invitation

36 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

Clinical Trials

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

DLIT-AML

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T